Navigation Links
Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
Date:5/23/2011

INDIANAPOLIS, May 23, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that it has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a newly-formed and privately-held biotechnology company. BioCritica, based in Central Indiana, will initially focus on the continued U.S. development and commercialization of Xigris® (drotrecogin alfa (activated)), Lilly's medicine for severe sepsis. BioCritica intends to ultimately build a broad portfolio of innovative, hospital-based critical care medicines.

As part of a licensing agreement, BioCritica will acquire the U.S. development and commercialization rights to Xigris and will also receive the rights to potentially acquire several critical care compounds currently in pre-clinical development at Lilly. The collaboration also includes a supply agreement, a services agreement and an option for BioCritica to potentially acquire the development and commercialization rights to Xigris outside the U.S. at a later date. In return, Lilly will receive royalties on future U.S. sales of Xigris and will also receive an equity stake in BioCritica. Specific financial terms of the transaction are not being disclosed.

The creation of BioCritica received the support of the Indiana Economic Development Corporation (IEDC) and BioCrossroads, Indiana's public-private initiative to grow, advance and invest in the life sciences. BioCritica's formation and the Lilly-BioCritica collaboration are the latest successes in the state's efforts to attract new life sciences companies to Central Indiana.  

"We are pleased to announce the formation of a new life sciences company in Central Indiana, BioCritica. The collaboration between Lilly and BioCritica will benefit both companies, as well as the patients we serve and the Indianapolis community in which we operate," sai
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Determined Best Dose and Showed 55 Percent Response Rate With Lilly Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients
2. David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly
3. Lilly Provides Its Perspective in Response to Amylin Lawsuit
4. Lilly Provides Statement in Response to Amylin Lawsuit
5. Lilly USA, LLC Launches TruAssist for Patients
6. Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO
7. Lilly Oncology to Present New Data on Nine of Its Pipeline Molecules at ASCO 2011
8. Amylin Pharmaceuticals Files Suit Against Eli Lilly
9. Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trusts Grow What Works Campaign
10. U.S. District Court Order Maintains Patent Exclusivity for Lillys Cymbalta
11. Lilly and Medtronic Announce Drug-Device Collaboration for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... PLAINFIELD, N.J. , May 16, 2013  PTC ... registration statement on Form S-1 with the U.S. Securities ... public offering of its common stock. The number of ... the offering have not been determined. (Logo:  ... Credit Suisse are acting as joint book-running managers for ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
(Date:5/16/2013)... May 16, 2013  Alere Inc. (NYSE: ALR ... of their health at home through the merger of rapid ... $3.00 per share on its Series B Convertible Perpetual Preferred ... 2013 to holders of record of Series B stock at ... Such payment will cover the amount of all dividends accrued ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Calif., Dec. 12 BioForm Medical,Inc. (Nasdaq: ... multi-center,randomized, blinded comparative study of nasolabial fold treatments,reporting ... reported after treatment with either Juvederm(TM) or Perlane(R). ... December 2007 Filler Issue of,the Journal of Dermatologic ...
... Solvay Pharmaceuticals, Inc.,announced today that the company ... and Drug Administration (FDA) to fully address the ... in its meeting to,consider tedisamil as a treatment ... normal sinus rhythm (NSR)., The Committee voted ...
Cached Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation 2
(Date:5/18/2013)... 2013 The “Sleep Apnea Diagnostic & ... Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] ... analyzes and studies the major market drivers, restraints, and ... the World. , Browse , ... Figures , 318 pagesand in-depth TOC ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric Cressey’s ... is all about is getting results in the fastest amount ... ’s Stan Stevenson, prompting an investigative review. , “ ... system” designed to make you faster, stronger, fitter and trimmer ... in the gym. The training manual and exercise video database ...
(Date:5/18/2013)... Morro Bay, CA (PRWEB) May 18, 2013 ... salon , has recently completed a stylish renovation that ... and advanced specialties. , From the ground up, this ... been improved with fresh flooring, soothing colors and comfortable ... have been installed, including an Apilus epilator machine. ...
(Date:5/18/2013)... 18, 2013 Dr. Robert Tracey, an area ... employs his knowledge of the root causes of sleep ... With May being Better Sleep Month, Dr. Tracey points out ... chronic sleep disorder, and sleep apnea is one of the ... person will essentially stop breathing at different times while sleeping. ...
(Date:5/18/2013)... May 18, 2013 The topics that will ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... PDUs) for attending them. , These trainings are suitable for ... also ideal for those who will be a part of ... who want to explore Agile and Scrum, but are unsure ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3
... believe a brain imaging approach that combines standard ... techniques could lead to more effective diagnoses in ... the brain. ,James Leach, MD, reports ... American Journal of Neuroradiology. This is the first ...
... mutations of the gene responsible for the debilitating ... study claims to make treatment more specific for ethnic groups ... by genetic tests. , Says Irwin McLean ... University of Dundee, who led the study:” Once we cracked ...
... are describing as a “ U-turn of dramatic proportions”, a ... can in fact prevent// them from the risks of heart ... of the American Medical Association shows that hormone replacement therapy ... put such women at higher risks of heart attacks and ...
... least 2,500 years old. It claims to be the world's oldest inhabited ... ,Its population of 1.74 millions is said to be living ... is a scarce commodity, whatever water is available is soaked up by ... with cheeks bulging bizarrely as they get their fix. It is a ...
... be worth over $200 million and is expected to grow to ... ,The growth of the food industry is also going ... industry, which is currently growing at nine percent. ,These ... food meet to be held in New Delhi April 10-11, which ...
... even faster than the climate around it since the late ... of 2040//, according to a study by professors at ... largest freshwater lake in the world by surface area. ... increased about 4.5 degrees since 1979, compared with about a ...
Cached Medicine News:Health News:Combined Imaging Approach may Be Effective in Diagnosing Some Brain Clots 2Health News:More Mutations Of Gene That Cause Skin Disorders And Asthma Discovered 2Health News:Hormone Replacement Therapy- Not A Fallen Angel 2Health News:Drug Uses Up Water in Yemeni Capital, People Must Relocate 2
Table mount stabilizer system...
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy....
... Nd:YAG laser system with a wavelength of 1,064 ... superficial as well as red and blue vein ... patients with darker skin types (1 to 6) ... general improvement of skin texture. The handpieces special ...
... SINON is a Q-switched ... wavelength of 694 nm. High ... Pulses - This combination of ... pulses in Q-switched mode effectively ...
Medicine Products: